Here’s an idea for the next episode of “The Eli Manning Show.” The former quarterback visits various investors and tries to pool enough money to buy a minority ownership stake in the Giants.

The range and depth of the post playing career of Eli Manning is incredible. But him and his kids being mic’d up while in the front row at an NHL playoff game may now move to the top of the list.

The last couple of quarters have been very favorable for Eli Lilly and Company (NYSE:LLY) and its position in the obesity and adjacent markets. The main competitor Novo Nordisk A/S (NVO ...

Giants legend Eli Manning could soon own a minority stake of his old team. According to a report from Bloomberg, the former quarterback is putting together an investment group to bid for a piece ...

Eli Manning has his sights on the Giants. The two-time Super Bowl winning quarterback is putting together an ownership group to bid for a piece of the Giants, according to Bloomberg. The report ...

Pharmaceutical company Eli Lilly announced promising clinical trial results this week for a daily pill to treat obesity and diabetes. Besides the good news of minimal side effects and impressive ...

Legendary New York Giants quarterback Eli Manning may become more than just a franchise icon in the near future, as Bloomberg reported this week that he has spoken to potential investors ...

New York Giants legend Eli Manning had a smooth transition from the gridiron to the media, but he's seemingly not done finding new activities. Besides his successful joint show with brother ...

Chief executive officers from Nvidia Corp., Johnson & Johnson, Eli Lilly & Co., General Electric Co. and SoftBank Group Corp. are among corporate leaders slated to visit the White House on ...

Eagles cornerback Eli Ricks stirred controversy during the team's White House visit by publicly expressing his admiration for Ivanka Trump on social media. His tweets, complimenting her appearance ...

Research from the Pharmaceutical Research and Manufacturers of America (PhRMA) cited by Reuters said the costs could ripple to consumers, raising U.S. drug prices by nearly 13%. In 2023, the U.S ...